CHANGE IN RATINGS
downgraded at BB&T Capital from Buy to Hold. $48 price target. Valuation call, as the stock is up 13% in the past three weeks alone and trades at a 9% premium to ADM.
upgraded at Deutsche Bank to Buy from Hold. Expect company to surprise investors with a number of well-conceived strategic changes involving the integration of TRI. Price target raised to $47 from $39.
upgraded at UBS to Buy rating from Neutral. Price target jumps to $50 from $41 and FY2008 eps estimates rise to $2.51 from $2.21.
upgraded at JP Morgan from Neutral to Overweight. See increased leverage in the Government segment over the next couple of years. 2008 earnings estimate also raised to $5.40 a share.
upgraded at Citigroup to a buy with an $80 price target.
downgraded at Deutsche Bank to Sell from Hold. The company's guided first quarter levels were well below consensus expectations. Competitive environment creates need for urgency at Palm. Price target lowered to $14.
Palm 2008 estimates cut at Credit Suisse to 15 cents from 36 cents after disappointing guidance. Maintained Neutral rating.
upgraded at Goldman Sachs to Buy from Neutral, increased gross booking expectations. See continued strength in international growth and margin expansion. Price target raised to $80 from $62.
initiated at UBS with Buy rating. Price target set at $87 and FY 2008 eps estimates start at $5.60.
Research In Motion
2008 estimates raised at Goldman to $5.48 from $4.47 following strong Q1 results driven by strength in subscriber adds. See improving product line, better ARPUs and subscriber add rates. Price target raised to $260 from $240. Maintained Buy rating.
Research in Motion numbers raised at UBS. Price target upped to $235 from $210 and FY 2008 eps estimates rise to $5.58 from $4.80. Reiterates Buy rating.
Research in Motion upgraded to Top Pick at RBC Capital. Estimates also increased, as sales and earnings momentum is increasing. Several pending growth drivers are not yet priced into the stock. $250 price target.
Research in Motion target price raised at Credit Suisse to $210 from $170 following strong quarterly results. However maintains Neutral rating as it see margin pressures over time.
Rohm & Haas
upgraded at Deutsche Bank to Buy from Hold. Investors concerns including housing exposure, electronics margins, and monomer earnings are overdone. Upside underappreciated. Price target raised to $65.
STOCK COMMENTS / EPS CHANGES
target price raised at Credit Suisse to $50 from $41 after company raised EPS guidance. Maintained Outperform rating.
Accenture numbers raised at UBS. FY 2008 eps estimates rise to $2.22 from $2.19, while price target holds at $49. Reiterates Buy rating.
numbers raised at UBS. Price target jumps to $98 from $84 and FY 2008 eps estimates rise to $8.13 from $7.61. Reiterates Buy rating.
MSC Ind. Direct
numbers boosted at Jefferies. Price target upped to $62 from $56 and FY 2008 eps estimates rise to $3.00 from $2.88. Reiterates Buy rating.
2007 estimates cut to ($0.62) from ($0.40) at Goldman. Weak Q2 results included poor sales results including continued deterioration in DRAM ASPs. Expect ongoing weakness in DRAM fundamentals. Maintained Sell rating.
Micron numbers lowered at UBS. FY 2008 eps estimates drop to $0.13 from $0.19, while price target holds at $17. Reiterates Buy rating.
numbers raised at UBS. Price target upped to $11 from $10 and FY 2008 eps estimates rise to $0.19 from $0.12. Reiterates Buy rating.